Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2013 by Ziv Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Osamah Hussein, Ziv Hospital
ClinicalTrials.gov Identifier:
NCT01215383
First received: October 4, 2010
Last updated: February 19, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)